Savita Dandapani
Radiation Oncology · Duarte, CANPI 1619141751
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $368 of the $596 with a category attached, or 61.8%. Medtronic accounts for 63.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $379 and has fallen 96.1% since, to $15 in 2025. That places this record below the midpoint for radiation oncology clinicians in CA, where the typical reported total is $477.
Across 8 payments — averaging $74.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$379
- AstraZeneca$112
- Bayer$50
- Brainlab, Inc.$39
- Reflexion Medical, Inc.$15
Across 8 payments — averaging $34,875 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$265K
- Reflexion Medical, Inc.$14K
What the payments were for
- Travel & lodging$22838%
- Food & beverage$36862%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $379 |
| AstraZeneca | 1 | $112 |
| Bayer | 1 | $50 |
| Brainlab, Inc. | 1 | $39 |
| Reflexion Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OSTEOCOOL RF ABLATION$228
- IMFINZI$112
How this compares
$596 in reported general payments places this provider in the 50th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 11 | $175 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Duarte
- Arya AminiDuarte$265K
- Hyun KimDuarte$97K
- Terence WilliamsDuarte$14K
- Rakesh PatelLos Gatos$1.3M
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
- Rizwan NuraniApple Valley$220K
- Drew MoghanakiLos Angeles$183K
- Jyoti MayadevSan Diego$170K
- Percy LeeIrvine$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.